LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.

    Rutter, Joni L / Goldstein, Alisa M / Dávila, Michael R / Tucker, Margaret A / Struewing, Jeffery P

    Oncogene

    2003  Volume 22, Issue 28, Page(s) 4444–4448

    Abstract: The CDKN2A gene, which encodes the proteins p16(INK4a) and p14(ARF), is located on chromosome 9p21. Germline mutations at this locus increase susceptibility to cutaneous malignant melanoma (CMM). In general, missense and nonsense mutations are primarily ... ...

    Abstract The CDKN2A gene, which encodes the proteins p16(INK4a) and p14(ARF), is located on chromosome 9p21. Germline mutations at this locus increase susceptibility to cutaneous malignant melanoma (CMM). In general, missense and nonsense mutations are primarily responsible for defective p16(INK4a) and possibly p14(ARF) protein function and account for approximately 20% of inherited CMM cases. We report a G>T transversion mutation in the last nucleotide of exon 2, affecting the aspartic acid residue at position 153 of CDKN2A-p16(INK4a) in a proband with melanoma. If splicing were unaffected, this mutation would change Asp to Tyr. RT-PCR analysis, however, revealed that this mutation, which we have termed D153spl(c.457G>T), and a previously described mutation at the next nucleotide, IVS2+1G>T, result in identical aberrant splicing affecting both p16(INK4a) and p14(ARF). The two main alternate splice products for each of the two normal transcripts includes a 74 bp deletion in exon 2, revealing a cryptic splice site, and the complete skipping of exon 2. The dual inactivation of p16(INK4a) and p14(ARF) may contribute to the CMM in these families.
    MeSH term(s) 3' Untranslated Regions ; Amino Acid Sequence ; Base Sequence ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; Genes, p16 ; Humans ; Melanoma/genetics ; Molecular Sequence Data ; Point Mutation ; RNA Splicing ; Skin Neoplasms/genetics ; Tumor Suppressor Protein p14ARF/genetics
    Chemical Substances 3' Untranslated Regions ; Cyclin-Dependent Kinase Inhibitor p16 ; Tumor Suppressor Protein p14ARF
    Language English
    Publishing date 2003-07-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 639046-8
    ISSN 1476-5594 ; 0950-9232
    ISSN (online) 1476-5594
    ISSN 0950-9232
    DOI 10.1038/sj.onc.1206564
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 2218: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.

    Rutter, Joni L / Smith, Amelia M / Dávila, Michael R / Sigurdson, Alice J / Giusti, Ruthann M / Pineda, Marbin A / Doody, Michele M / Tucker, Margaret A / Greene, Mark H / Zhang, Jinghui / Struewing, Jeffery P

    Human mutation

    2003  Volume 22, Issue 2, Page(s) 121–128

    Abstract: Two potential breast cancer susceptibility genes, encoding the BRCA1-interacting proteins ZNF350 (or ZBRK1) and BRIP1 (or BACH1), have been identified in yeast two-hybrid screens. We sequenced these genes in probands from 21 families with potentially ... ...

    Abstract Two potential breast cancer susceptibility genes, encoding the BRCA1-interacting proteins ZNF350 (or ZBRK1) and BRIP1 (or BACH1), have been identified in yeast two-hybrid screens. We sequenced these genes in probands from 21 families with potentially inherited breast/ovarian cancer, all of which were negative for BRCA1/BRCA2 mutations. Families had at least one case of male breast cancer, two cases of ovarian cancer, or three or more cases of breast and ovarian cancer. In addition, 58 early-onset (before age 35) breast cancer cases and 30 reference individuals were analyzed. Of 17 variants detected in ZBRK1, a missense mutation Val524Ile was identified in the proband of one high-risk family, but no other family members were available for testing. Of 25 variants identified in BRIP1, in addition to four common silent or missense mutations, we identified Gln540Leu, a non-conservative amino acid change, in a single familial proband with inflammatory breast cancer, but this mutation was not present in her three relatives with breast cancer. Haplotype analysis suggests that all ZBRK1 SNPs fall within a single block with two SNPs capturing 92% of the haplotype diversity, while the BRIP1 SNPs fall in two blocks, with five SNPs capturing 89% of the haplotype diversity. Based on sequencing of ZBRK1 and BRIP1 in 21 BRCA1/2-negative probands from inherited breast/ovarian cancer families, it appears unlikely that mutations in these genes account for a significant fraction of inherited breast cancer. Further analysis in unselected cases will be required to know whether the identified variants play a role in genetic predisposition to breast cancer in the general population. Hum Mutat 22:121-128, 2003. Published 2003 Wiley-Liss, Inc.
    MeSH term(s) BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Basic-Leucine Zipper Transcription Factors ; Breast Neoplasms/genetics ; Breast Neoplasms, Male/genetics ; DNA Mutational Analysis/methods ; DNA, Neoplasm/genetics ; DNA-Binding Proteins ; Family ; Fanconi Anemia Complementation Group Proteins ; Female ; Gene Expression Regulation/genetics ; Gene Expression Regulation/physiology ; Gene Expression Regulation, Neoplastic/genetics ; Genes, BRCA1 ; Genes, BRCA2 ; Haplotypes/genetics ; Humans ; Leucine Zippers/genetics ; Linkage Disequilibrium/genetics ; Male ; Mutation, Missense/genetics ; Ovarian Neoplasms/genetics ; Pedigree ; Repressor Proteins/genetics ; Repressor Proteins/physiology ; Transcription Factors/genetics ; Transcription Factors/physiology ; Zinc Fingers/genetics
    Chemical Substances BACH1 protein, human ; BRCA1 Protein ; BRCA2 Protein ; Basic-Leucine Zipper Transcription Factors ; DNA, Neoplasm ; DNA-Binding Proteins ; Fanconi Anemia Complementation Group Proteins ; Repressor Proteins ; Transcription Factors ; ZNF350 protein, human
    Language English
    Publishing date 2003-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1126646-6
    ISSN 1098-1004 ; 1059-7794
    ISSN (online) 1098-1004
    ISSN 1059-7794
    DOI 10.1002/humu.10238
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3586: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top